###begin article-title 0
Search for a correlation between telomere length and severity of retinitis pigmentosa due to the dominant rhodopsin Pro23His mutation
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
Great variation exists in the age of onset of symptoms and the severity of disease at a given age in patients with retinitis pigmentosa (RP). The final pathway for this disease may involve apoptotic photoreceptor cell death. Telomere length is associated with biologic aging, senescence, and apoptosis. We evaluated whether the length of telomeres in leukocytes correlated with the severity of RP in patients with the Pro23His rhodopsin mutation who have shown marked heterogeneity in disease severity.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 373 381 <span type="species:ncbi:9606">patients</span>
We evaluated 122 patients with the Pro23His rhodopsin mutation. The patients' retinal function was stratified according to their 30-Hz cone electroretinogram (ERG). The length of telomeres in leukocytes was measured by the quantitative real time polymerase chain reaction (qRT-PCR) method in the 15 patients with the highest age-adjusted 30-Hz ERG amplitudes and in the 15 patients with the lowest amplitudes.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 162 170 <span type="species:ncbi:9606">patients</span>
Mean leukocyte telomere length was similar in the 15 patients with the highest cone ERG amplitudes (median: 0.40 units; interquartile range 0.36-0.56) and the 15 patients with the lowest cone amplitudes (median: 0.41 units; inter quartile range 0.34 -0.64; p=0.95).
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 119 127 <span type="species:ncbi:9606">patients</span>
We found no evidence for an association between telomere length and the severity of RP as monitored by the cone ERG in patients with the Pro23His rhodopsin mutation.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 812 813 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 763 771 <span type="species:ncbi:9606">patients</span>
Retinitis pigmentosa (RP) is a group of inherited retinal degenerations with progressive photoreceptor cell death typically causing night blindness, constricted visual fields, and in later stages, a decrease in visual acuity. As the condition progresses, the cone electroretinogram (ERG) amplitude decreases. Mutations in the rhodopsin gene (RHO; OMIM ID: ) account for about 25% of the dominantly inherited RP cases and less than a few percent of recessively inherited cases [1-4]. The Pro23His mutation is the most frequently reported rhodopsin mutation in the United States [5], accounting for about 8.5% of all dominant RP cases or about 1/3 of those with a dominant rhodopsin mutation [6]. Interfamilial and intrafamilial variation in disease severity among patients with this mutation have been described [7,8], suggesting that factors besides the primary gene defect contribute to the disease.
###end p 11
###begin p 12
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
Telomeres are structures at the ends of chromosome arms consisting of tandem repeats of the nucleotide sequence TTAGGG. These repetitive elements stabilize chromosomes by preventing fusion with other chromosome ends and by impeding degradation of coding DNA [9-11]. Short telomere length has been associated with apoptosis [12-14]. Telomere length is dependent on the number of previous cell divisions and, thus, decreases with age. This decrease is compensated in part by telomerase, which adds TTAGGG tandem repeats to the 3' end of the DNA strand [15-19]. Telomere length is highly variable among individuals, and this variation is detectable at birth [20-22]. Telomere lengths are similar in different tissues of the same individual, so the analysis of one cell type (e.g., leukocytes) reflects the telomere size throughout that individual [23,24].
###end p 12
###begin p 13
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
Previous studies have shown an inverse relationship between leukocyte telomere length and the occurrence of age-related diseases such as chronic heart failure [25] and dementia [26]. Shorter telomere length has also been associated with disease severity [27].
###end p 13
###begin p 14
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 313 321 <span type="species:ncbi:9606">patients</span>
In this study we evaluated the possible association between telomere length and the severity of RP. We hypothesized that individuals with shorter telomere lengths may have more severe photoreceptor degeneration. We evaluated 122 patients who had autosomal dominant RP due to the Pro23His mutation and selected 15 patients with the best preserved retinal function and the 15 who had the least preserved retinal function. Telomere length was compared with the loss of retinal function as indicated by the amplitude of the 30-Hz cone ERG.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient selection
###end title 16
###begin p 17
###xml 384 387 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 182 187 <span type="species:ncbi:9606">Human</span>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
###xml 394 402 <span type="species:ncbi:9606">Patients</span>
###xml 488 496 <span type="species:ncbi:9606">Patients</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 740 748 <span type="species:ncbi:9606">patients</span>
This study conformed to the Declaration of Helsinki and was approved by the Institutional Review Boards of Harvard Medical School and the Massachusetts Eye and Ear Infirmary and the Human Subjects Committee of the Harvard School of Public Health. Informed consent was obtained from all patients. We evaluated 122 RP patients previously found to have the dominant mutation Pro23His in RHO [28]. Patients were recruited from the files of the Berman-Gund Laboratory, Harvard Medical School. Patients had elevated final dark adaptation thresholds and reduced rod ERGs; all had attenuated retinal arterioles and most had intraretinal bone spicule pigment around the periphery. The general health of the patients was good. Blood samples from the patients were obtained through phlebotomy and leucocyte DNA was isolated using a Phenol/Chloroform extraction.
###end p 17
###begin title 18
Measurements of retinal function
###end title 18
###begin p 19
###xml 683 685 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 686 688 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
Retinal function was evaluated based on the ERG amplitude recorded in response to 30-Hz white flashes. Full-field ERG responses were obtained following pupil dilation using one drop of a solution containing 10% phenylephrine hydrochloride and 1% cyclopentolate hydrochloride (Akorn, inc., Buffalo Grove, IL) and 45 min of dark adaptation. ERGs were recorded with a contact lens electrode placed on the cornea topically anesthetized with one drop of 0.5% proparacaine hydrochloride (Alcon Laboratories, Inc. Fort Worth, TX). Responses below 10 muV were recorded with narrow band-pass filtering and then computer averaged to increase the signal to noise ratio as described previously [29,30]. Amplitudes were averaged between the two eyes (when results from both eyes were available) and adjusted for age and refractive error.
###end p 19
###begin title 20
Telomere lengths
###end title 20
###begin p 21
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
The relative telomere lengths were determined using a modified quantitative real time polymerase chain reaction (qRT-PCR) [31,32]. Briefly, the 7900 HT thermocycler (Applied Biosystems, Foster city, CA) was used to obtain the relative length of telomeres, expressed as the ratio between the repeat copy number of telomeres (T) and a reference single-copy gene (S; 36B4 gene, chromosome 12). All samples were compared with the same reference DNA sample. This method has been shown to correlate with Southern blot measurements of telomere length [33,34].
###end p 21
###begin p 22
For each reaction 5 ng of DNA were dried in the well of a reaction plate and resuspended in 10 mul of PCR reaction mix, which contained 1X Qiagen Quantitect Sybr Green Master Mix, 2.5 mM of dithiothreitol, and primers. Primers for the telomere reaction were 270 nM of the sense primer (GGT TTT TGA GGG TGA GGG TGA GGG TGA GGG TGA GGG T) and 900 nM of the antisense primer (TCC CGA CTA TCC CTA TCC CTA TCC CTA TCC CTA TCC CTA). Primers for the 36B4 reaction were 300 nM of the sense primer (CAG CAA GTG GGA AGG TGT AAT CC) and 500 nM of the antisense primer (CCC ATT CTA TCA TCA ACG GGT ACA A). The temperature for the first 5 min was 95 degreesC; this was followed by 40 cycles consisting of 15 s at 95 degreesC and 2 min at 54 degreesC for the telomere reaction or 1 min at 58 degreesC for the 36B4 reaction. ABI 7900HT software calculated the cycle threshold for the Telomere (T) and reference gene (S) for each sample. The ratio T:S represented the relative amount of telomere DNA compared to single copy DNA and therefore corresponded to relative telomere length. All samples were analyzed in triplicate and the coefficient of variation (CV), describing the amount of repeat variability, was calculated.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 684 685 684 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
We confined our analysis of telomere length to sets of patients at the extremes of disease severity as determined by cone 30-Hz ERG amplitudes. Individuals at the extremes for a continuously variable trait (such as disease severity) provided the most power for uncovering the responsible factors, since they are most likely to differ in the level of the responsible factors or their frequency (see, for example, power calculations for mapping genes for quantitative traits [35]). First, the relative telomere lengths (T:S ratios) in the high and low ERG amplitude groups were compared by means of a two-tailed Mann-Whitney U test. Second, a linear regression analysis compared the loge 30-Hz ERG amplitude to the T:S ratio adjusting for age and refractive error. The Spearman correlation was used to test the association between age and telomere length. A p-value of <0.05 was considered statistically significant. The aforedescribed calculations were performed with SPSS version 14 software (SPSS, Chicago, IL) or with JMP, version 6 (SAS Institute, Cary, NC).
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 26
###begin p 27
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 1640 1647 1640 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
###xml 413 421 <span type="species:ncbi:9606">patients</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
###xml 1326 1334 <span type="species:ncbi:9606">patients</span>
###xml 1377 1385 <span type="species:ncbi:9606">patients</span>
###xml 1588 1595 <span type="species:ncbi:9606">patient</span>
We ranked 122 patients with the RHO-Pro23His mutation according to their mean 30-Hz ERG amplitude, adjusted for age and refractive error. After excluding a few outlier patients with respect to age, we selected the 15 with the highest 30-Hz ERG amplitude and the 15 with lowest. The 15 patients with the least severe RP (i.e., those with the highest ERG amplitudes) consisted of nine males and six females. The 15 patients with the most severe disease (i.e., those with the lowest ERG amplitudes) comprised eight males and seven females. The mean age at time of phlebotomy for DNA samples from these two groups was 46.7 years (range: 27-58) and 45.1 years (range: 31-62), respectively. Many of the 122 patients were related to others in this set. Of the 30 individuals included in the analysis of the least and most severely affected, 14 were first degree relatives (siblings). An additional nine individuals were also related to others in the analysis set but were more distantly related. Among the first degree relatives, four sets of two siblings appeared in the group with high ERG amplitudes (least severe), one set of three siblings appeared in the group with low ERG amplitudes (most severe), and one sibship was split among the groups with two siblings in the most severe group and one in the least severe group. Seven patients were not related to any of the 30 extreme patients in the in the analysis set. No unaffected controls were included since we were only interested in the variation of telomere length related to disease severity within this group of Pro23His mutants. For patient characteristics and individual results, see Table 1.
###end p 27
###begin title 28
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients included in high and low ERG amplitude groups.
###end title 28
###begin p 29
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
###xml 333 340 <span type="species:ncbi:9606">patient</span>
###xml 346 353 <span type="species:ncbi:9606">patient</span>
###xml 733 741 <span type="species:ncbi:9606">patients</span>
This table lists the 30 Hz cone ERG amplitudes averaged across both eyes (Av30Hz ERG) for the 15 patients included in the high ERG amplitude group (least severely affected) and the 15 patients included in the low ERG amplitude group (most severely affected) along with the relative telomere lengths (ie. T/S ratio) obtained for each patient, the patient's age at phlebotomy, their gender and any first degree relatives also included in this study. Age ranges, gender distribution and T/S ratios were similar between the two groups whereas the 30 Hz ERG amplitudes were on average nearly 100 fold greater in the high ERG group than the low ERG group. Amplitudes marked with an * indicate that data was available for only one eye. All patients had reduced or nondetectable rod ERG amplitudes (data not shown); some still had normal cone ERG amplitudes (normal range=50-125 muV).
###end p 29
###begin title 30
Analysis of the relative telomere lengths
###end title 30
###begin p 31
###xml 595 603 595 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 1103 1104 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sub>
###xml 192 199 <span type="species:ncbi:9606">patient</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
###xml 845 853 <span type="species:ncbi:9606">patients</span>
###xml 1006 1014 <span type="species:ncbi:9606">patients</span>
The coefficient of variation in our study was satisfactorily low with 1.27% for the T assay and 0.64% for the S assay. Spearman's correlation test showed a modest inverse relationship between patient age and relative telomere length in the 30 patients (r=-0.38; p=0.037). We found no significant difference in T:S ratio between the 15 patients with the highest cone ERG amplitudes (median: 0.40 units; interquartile range 0.36-0.56) and the 15 patients with the lowest cone ERG amplitudes (median: 0.41 units; interquartile range 0.34 -0.64; p=0.95) using the Mann-Whitney U nonparametric test (Figure 1). The results did not change when first degree relatives were excluded from the analysis (n=22): T:S ratios of 11 patients with highest cone ERG amplitudes (median: 0.39 units; interquartile range 0.36-0.56) were similar to the ratios of 11 patients with the lowest cone ERG amplitudes (median: 0.36 units; interquartile range 0.33 -0.64; p=0.38). Multiple regression analysis of the total group of 30 patients, adjusting for age and refractive error, also showed no significant relation between loge 30 Hz-ERG amplitude and telomere T:S ratio (t=-0.75; p=0.46).
###end p 31
###begin p 32
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Relative telomere lengths in Pro23His RP patients. Boxplot showing no difference in T:S ratio's between patients with high- or low ERG amplitudes. The shaded boxes indicate the interquartile range. The horizontal line in each shaded box denotes the median, and the error bars mark the upper and lower 95 percentiles of the T:S ratio.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 436 439 436 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r48">48</xref>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
The rhodopsin gene product is a transmembrane G-coupled protein (opsin). It is found in the rod outer segments, and, when bound with chromophore, mediates the initial steps of the phototransduction cascade [36,37]. The RHO-Pro23His mutation encodes a misfolded protein that aggregates within the endoplasmic reticulum [38,39] and seems to activate apoptosis by the unfolded protein response (UPR) [40-42]. On average, patients with the RHO-Pro23His mutation tend to have milder disease compared to those with other rhodopsin mutations [43-47]. However, there is great variability in disease severity among those with Pro23His, and this variation can be objectively measured with ERGs [48].
###end p 34
###begin p 35
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RHO</italic>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r49">49</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 1610 1612 1610 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r51">51</xref>
###xml 1613 1615 1613 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r52">52</xref>
###xml 170 178 <span type="species:ncbi:9606">patients</span>
###xml 414 422 <span type="species:ncbi:9606">patients</span>
###xml 793 801 <span type="species:ncbi:9606">patients</span>
###xml 1022 1030 <span type="species:ncbi:9606">patients</span>
Since photoreceptors in RP appear to die ultimately through apoptosis, and since cells with chromosomes with short telomeres are prone to apoptosis, we hypothesized that patients with short telomeres might have more severe disease because their photoreceptors would more rapidly undergo apoptosis in response to the deleterious effects of RHO-Pro23His. To test this hypothesis, we confined our analysis to sets of patients at the extremes of disease severity as determined by 30-Hz cone ERG amplitudes. We found no evidence for an association between telomere length and severity of RP. However, a limitation of our analysis method must be noted: We used DNA derived from dividing leukocytes, since our cells of interest, the nondividing retinal photoreceptors, were not available from living patients. Although it is reported that telomere size is highly correlated among tissues [49,50], it is known that dividing cells are subject to changes in telomere length with the main known factor being age. Since our groups of patients with mild and severe RP were of about the same ages, and since the effect of age is relatively small compared to the individual differences in telomere length, we assumed that the telomere length in the peripheral leucocytes reflected the telomere length in nondividing photoreceptor cells. However, a possible difference in telomere lengths between these two cell types cannot be ruled out. Our method using qRT-PCR measurements of telomere lengths has successfully been used in other studies and has been shown to correlate to the Southern blot method of telomere measurement [51,52]. However both methods provide only an estimate of actual telomere length.
###end p 35
###begin title 36
Acknowledgments
###end title 36
###begin p 37
This work was supported by NEI grants EY00169, EY08683, NIH grants CA082838 and CA132190, and the Foundation Fighting Blindness (Owing Mills, MD).
###end p 37
###begin title 38
References
###end title 38
###begin article-title 39
Retinitis pigmentosa.
###end article-title 39
###begin article-title 40
Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis.
###end article-title 40
###begin article-title 41
Rhodopsin mutations in autosomal dominant retinitis pigmentosa.
###end article-title 41
###begin article-title 42
Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies.
###end article-title 42
###begin article-title 43
A point mutation of the rhodopsin gene in one form of retinitis pigmentosa.
###end article-title 43
###begin article-title 44
Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa.
###end article-title 44
###begin article-title 45
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His).
###end article-title 45
###begin article-title 46
Histopathologic study of variation in severity of retinitis pigmentosa due to the dominant rhodopsin mutation Pro23His.
###end article-title 46
###begin article-title 47
###xml 35 40 <span type="species:ncbi:9606">human</span>
Telomeres shorten during ageing of human fibroblasts.
###end article-title 47
###begin article-title 48
Telomere maintenance and disease.
###end article-title 48
###begin article-title 49
Telomeres and their control.
###end article-title 49
###begin article-title 50
###xml 35 40 <span type="species:ncbi:9606">human</span>
Telomeres shorten during ageing of human fibroblasts.
###end article-title 50
###begin article-title 51
Telomere length in the newborn.
###end article-title 51
###begin article-title 52
###xml 58 63 <span type="species:ncbi:9606">human</span>
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.
###end article-title 52
###begin article-title 53
###xml 35 40 <span type="species:ncbi:9606">human</span>
Telomeres shorten during ageing of human fibroblasts.
###end article-title 53
###begin article-title 54
Telomere length regulation.
###end article-title 54
###begin article-title 55
###xml 22 27 <span type="species:ncbi:9606">human</span>
Telomere reduction in human colorectal carcinoma and with ageing.
###end article-title 55
###begin article-title 56
Telomere reduction in giant cell tumor of bone and with aging.
###end article-title 56
###begin article-title 57
###xml 60 65 <span type="species:ncbi:9606">human</span>
Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.
###end article-title 57
###begin article-title 58
Telomere length in the newborn.
###end article-title 58
###begin article-title 59
###xml 51 56 <span type="species:ncbi:9606">women</span>
Obesity, cigarette smoking, and telomere length in women.
###end article-title 59
###begin article-title 60
###xml 36 41 <span type="species:ncbi:9606">human</span>
Synchrony in telomere length of the human fetus.
###end article-title 60
###begin article-title 61
Telomere length in the newborn.
###end article-title 61
###begin article-title 62
Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages.
###end article-title 62
###begin article-title 63
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.
###end article-title 63
###begin article-title 64
Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia.
###end article-title 64
###begin article-title 65
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.
###end article-title 65
###begin article-title 66
Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa.
###end article-title 66
###begin article-title 67
Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa.
###end article-title 67
###begin article-title 68
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
###end article-title 68
###begin article-title 69
Telomere measurement by quantitative PCR.
###end article-title 69
###begin article-title 70
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.
###end article-title 70
###begin article-title 71
Accelerated telomere shortening in response to life stress.
###end article-title 71
###begin article-title 72
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.
###end article-title 72
###begin article-title 73
###xml 41 46 <span type="species:ncbi:9606">human</span>
The future of genetic studies of complex human diseases.
###end article-title 73
###begin article-title 74
Rhodopsin structure, function, and topography the Friedenwald lecture.
###end article-title 74
###begin article-title 75
I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor.
###end article-title 75
###begin article-title 76
Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa.
###end article-title 76
###begin article-title 77
Mutant rhodopsin transgene expression on a null background.
###end article-title 77
###begin article-title 78
Mutant rhodopsin transgene expression on a null background.
###end article-title 78
###begin article-title 79
A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system.
###end article-title 79
###begin article-title 80
Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa.
###end article-title 80
###begin article-title 81
Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa.
###end article-title 81
###begin article-title 82
Description of a new mutation in rhodopsin, Pro23Ala, and comparison with electroretinographic and clinical characteristics of the Pro23His mutation.
###end article-title 82
###begin article-title 83
Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23.
###end article-title 83
###begin article-title 84
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations.
###end article-title 84
###begin article-title 85
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine.
###end article-title 85
###begin article-title 86
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His).
###end article-title 86
###begin article-title 87
Telomere length in the newborn.
###end article-title 87
###begin article-title 88
Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages.
###end article-title 88
###begin article-title 89
Accelerated telomere shortening in response to life stress.
###end article-title 89
###begin article-title 90
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.
###end article-title 90

